Publications by authors named "A L Borghi"
The paper presents new evidence collected in the last five years supporting the Words As social Tools proposal on abstract concepts. We discuss findings revolving around three central tenets. First, we show that-like concrete concepts-also abstract concepts evoke sensorimotor experiences, even if to a lower extent, and that they are linked to inner experiences (e.
View Article and Find Full Text PDFArticle Synopsis
- This study examines topical corticosteroid phobia (TCP) in women with vulvar lichen sclerosus (VLS) and how it affects their treatment adherence and outcomes.
- The research involved 50 adult patients, who completed a questionnaire to assess their concerns about corticosteroid usage while undergoing a 12-week treatment, and most adhered well to the regimen.
- Findings indicate that TCP levels were low among participants and did not negatively impact either their adherence to treatment or the effectiveness of the corticosteroid therapy.
Head shape changes following spring-cranioplasty for craniosynostosis (CS) can be difficult to predict. While previous research has indicated a connection between surgical outcomes and calvarial bone microstructure ex-vivo, there exists a demand for identifying imaging biomarkers that can be translated into clinical settings and assist in predicting these outcomes. In this study, ten parietal (8 males, age 157 ± 26 days) and two occipital samples (males, age 1066 and 1162 days) were collected from CS patients who underwent spring cranioplasty procedures.
View Article and Find Full Text PDFArticle Synopsis
- This study investigates whether the timing of dupilumab administration affects its effectiveness in treating patients with atopic dermatitis (AD), considering the body's natural biological rhythms.
- The retrospective analysis involved 53 adult AD patients, comparing results based on whether they received dupilumab between midnight and noon or between noon and midnight over a 16-week period.
- Findings indicate that while all patients showed clinical improvement, those who took dupilumab between midnight and noon experienced more significant enhancements, suggesting potential for optimizing treatment timing in future research.